1. Kessler, R. C., Petukhova, M., Sampson, N. A., Zaslavsky, A. M., & Wittchen, H. U. (2012). Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States. International Journal of Methods in Psychiatric Research, 21(3), 169–184.
2. APA. (2013). Diagnostic and Statistical Manual of Mental Disorders (5th ed.). Arlington, VA: American Psychiatric Association.
3. To, S. E., Zepf, R. A., & Woods, A. G. (2005). The symptoms, neurobiology, and current pharmacological treatment of depression. The Journal of Neuroscience Nursing, 37(2), 102–107.
4. Woods, A. G. (2004). Understanding depression and diabetes. Diabetes Self-Management, 21(6), 6, 8, 11–12.
5. Strine, T. W., Mokdad, A. H., Balluz, L. S., Gonzalez, O., Crider, R., Berry, J. T., et al. (2008). Depression and anxiety in the United States: Findings from the 2006 behavioral risk factor surveillance system. Psychiatric Services, 59(12), 1383–1390.